Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

Our findings suggest that, unlike p-tau181 and p-tau231, plasma p-tau217 consistently aligns with cognitive status in A+ individuals and better reflects CSF biomarker abnormalities, reducing discrepancies between clinical and biochemical findings. Its association with baseline and future memory decline highlights its diagnostic and prognostic value, particularly when CSF analysis or PET is unavailable.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-05-15
DOI
https://doi.org/10.1212/wnl.0000000000213676
Citations
9
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
13.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

Lene Pålhaugen, Ragnhild Eide Skogseth, Michael Turton, Berglind Gísladóttir et al.
9 citations
Neurology
Dementia and Cognitive Impairment Research
13.24
article

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

Lene Pålhaugen, Ragnhild Eide Skogseth, Michael Turton, Berglind Gísladóttir, Kaj Blennow, Bjørn‐Eivind Kirsebom, Fernando González‐Ortiz, Knut Waterloo, Dag Aarsland, Yara Yakoub, Tormod Fladby, Geir Bråthen, Jonas Alexander Jarholm, Henrik Zetterberg, Arvid Rongve, Sylvia Villeneuve, Per Selnes, Peter Harrison, J Gundersen
article en
9 citations

Abstract

Our findings suggest that, unlike p-tau181 and p-tau231, plasma p-tau217 consistently aligns with cognitive status in A+ individuals and better reflects CSF biomarker abnormalities, reducing discrepancies between clinical and biochemical findings. Its association with baseline and future memory decline highlights its diagnostic and prognostic value, particularly when CSF analysis or PET is unavailable.

NeurologyVol. 104(11)
University of Science and Technology of China (CN), University Hospital of North Norway (NO), University of Wisconsin–Madison (US), King's College London (GB), University of Oslo (NO), Norwegian University of Science and Technology (NO), Douglas Mental Health University Institute (CA), Stavanger University Hospital (NO), Akershus University Hospital (NO), Sahlgrenska University Hospital (SE), Privatsykehuset Haugesund (NO), Sorbonne Université (FR), St Olav's University Hospital (NO), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Haraldsplass Diakonale Sykehus (NO), Institut du Cerveau (FR), University of Bergen (NO), University College London (GB), UiT The Arctic University of Norway (NO), University of Gothenburg (SE)
Openalex Percentile: Top 1%
Dementia and Cognitive Impairment Research
13.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.